Insulet (PODD) Tops Q1 EPS by 17c; Guides

Insulet (NASDAQ: PODD) reported Q1 EPS of $0.40, $0.17 better than the analyst estimate of $0.23. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $288.19 million.

GUIDANCE:

For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• FDA: classifies Insulet OmniPod pods recall as Class I due to serious injury risk
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM